Work

Early administration of tocilizumab (Toci) for the prevention of grade 4 cytokine release syndrome (CRS) after CD19-directed CAR T-cell therapy (CTL019)

Year: 2019

Type: article

Study design: Clinical Trial

Source: Cytotherapy

DOI: 10.1016/j.jcyt.2019.04.009

Authors: S. Kadauke, S. Maude, W. Gladney, L. Motley, V. Shenoy, C. Callahan, D. Baniewicz, D.T. Teachey, S. Grupp, A. DiNofia

Institutions: Children's Hospital of Philadelphia, University of Pennsylvania

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2944944828

FWCI: 1.089

Cites:

Cited by: 13

Related to: 10